Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes. Reply
- PMID: 34818492
- DOI: 10.1056/NEJMc2115776
Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes. Reply
Comment on
-
Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes.N Engl J Med. 2021 Nov 25;385(22):2105-2106. doi: 10.1056/NEJMc2115776. N Engl J Med. 2021. PMID: 34818489 No abstract available.
-
Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes.N Engl J Med. 2021 Nov 25;385(22):2106. doi: 10.1056/NEJMc2115776. N Engl J Med. 2021. PMID: 34818490 No abstract available.
-
Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes.N Engl J Med. 2021 Nov 25;385(22):2106-2107. doi: 10.1056/NEJMc2115776. N Engl J Med. 2021. PMID: 34818491 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical